RCT is instrumental in the commercial success of some of the world's most significant biomedical products. We remain committed to moving promising new drugs, diagnostics and devices from bench to bedside.
Many early-stage technologies cannot justify the expense of creating companies to develop them. RCT offers a cost-effective and flexible technology-development alternative. We can provide financial support and management to advance new technologies into clinical trials through a variety of business arrangements, including development partnerships and licensing.
Current Technology Development Interests
Our current interests include preclinical and clinical-stage drugs, diagnostics and devices (see: Medical Devices PDF) in the areas of:
- Cancer, pain and metabolic diseases (see: Oncology PDF)
- Cardiovascular diseases (see: Cardiovascular PDF)
- Back-of-the-eye and immune disorders (see: Ophthalmology or Inflammation PDFs)
- Infectious diseases and diagnostics (see: Anti-infectives PDF)
Tell Us About Your Technology
If you have a technology that meets our criteria and needs further development and commercialization, we would like to hear from you. Please contact us to begin a confidential review of your opportunity.
Submit Your Technology Overview
